Renal Blood Circulation as a Manifestation of Systemic Atherosclerosis.
Iino T, Watanabe H.
Intern Med. 2020 Apr 1;59(7):885-886. doi: 10.2169/internalmedicine.4145-19. Epub 2019 Dec 20.
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis.
International Cardiometabolic Working Group; Krentz A, Jacob S, Heiss C, Sattar N, Lim S, Khunti K, Eckel RH.
Atherosclerosis. 2024 Sep;396:118528. doi: 10.1016/j.atherosclerosis.2024.118528. Epub 2024 Jun 22.
Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases.
Devarajan A.
Clin Sci (Lond). 2018 Mar 20;132(6):615-626. doi: 10.1042/CS20171574. Print 2018 Mar 30.
Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.
Gungor O, Kircelli F, Toz H.
Int Urol Nephrol. 2013 Apr;45(2):441-7. doi: 10.1007/s11255-012-0197-x. Epub 2012 Jun 6.
Atherosclerosis and vascular calcification in chronic renal failure.
Campean V, Neureiter D, Varga I, Runk F, Reiman A, Garlichs C, Achenbach S, Nonnast-Daniel B, Amann K.
Kidney Blood Press Res. 2005;28(5-6):280-9. doi: 10.1159/000090182. Epub 2006 Mar 7.
Renal artery stenosis and accelerated atherosclerosis: which comes first?
Fava C, Minuz P, Patrignani P, Morganti A.
J Hypertens. 2006 Sep;24(9):1687-96. doi: 10.1097/01.hjh.0000242388.92225.2c.
Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease.
Zyga S, Christopoulou G, Malliarou M.
J Ren Care. 2011 Mar;37(1):12-5. doi: 10.1111/j.1755-6686.2011.00201.x.
Sympathetic Nervous System and Atherosclerosis.
Wang Y, Anesi J, Maier MC, Myers MA, Oqueli E, Sobey CG, Drummond GR, Denton KM.
Int J Mol Sci. 2023 Aug 23;24(17):13132. doi: 10.3390/ijms241713132.
Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis.
Jaisson S, Pietrement C, Gillery P.
Clin Chem. 2011 Nov;57(11):1499-505. doi: 10.1373/clinchem.2011.163188. Epub 2011 Jul 18.
Polyvascular atherosclerosis and renal dysfunction increase the odds of cognitive impairment in vascular disease: findings of the LipidCardio study.
König M, Palmer K, Malsch C, Steinhagen-Thiessen E, Demuth I.
Eur J Med Res. 2024 Feb 22;29(1):141. doi: 10.1186/s40001-024-01734-6.
